Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Actinium Pharmaceuticals Inc (ATNM)

7.57   -0.23 (-2.95%) 04-16 03:18
Open: 7.75 Pre. Close: 7.8
High: 7.81 Low: 7.53
Volume: 126,234 Market Cap: 146M
Actinium Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on developing and commercializing therapies for bone marrow transplant or adoptive cell therapies. Its lead product candidate is Iomab-B, which is in a pivotal Phase III clinical trial as an induction and conditioning agent in patients over the age of 55 with relapsed or refractory acute myeloid leukemia prior to receiving a bone marrow transplant, also known as a hematopoietic stem cell transplant. The company is also developing Actimab-A, its lead alpha-particle drug candidate that is in a Phase II trial for patients newly diagnosed with AML age 60 and over; and Actimab-M, a drug candidate, for the treatment of patients with penta refractory multiple myeloma in a Phase 1 clinical trial. Its Antibody Warhead Enabling technology platform is currently being utilized in a research collaboration with Astellas Pharma, Inc. The company was founded in 2000 and is based in New York, New York.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 7.832 - 7.875 7.875 - 7.911
Low: 7.397 - 7.458 7.458 - 7.507
Close: 7.481 - 7.571 7.571 - 7.644

Technical analysis

as of: 2021-04-15 4:54:54 PM
Overall:       
Stoxline posted a SELL today, downgraded from higher rating. Downward movement to be expected.
Target: Six months: 10.20     One year: 11.07
Support: Support1: 7.52    Support2: 6.26
Resistance: Resistance1: 8.73    Resistance2: 9.48
Pivot: 7.99
Moving Average: MA(5): 7.77     MA(20): 8.15
MA(100): 9.10     MA(250): 9.63
MACD: MACD(12,26): -0.21     Signal(9): -0.16
Stochastic oscillator: %K(14,3): 9.40     %D(3): 13.34
RSI: RSI(14): 37.89
52-week: High: 19.47  Low: 4.71  Change(%): 17.4
Average Vol(K): 3-Month: 36941  10-Days: 29062

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
ATNM has closed above bottom band by 15.0%. Bollinger Bands are 47.4% narrower than normal. The narrow width of the bands suggests low volatility as compared to ATNM's normal range. The bands have been in this narrow range for 4 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Wed, 07 Apr 2021
We Think Actinium Pharmaceuticals (NYSEMKT:ATNM) Can Afford To Drive Business Growth - Nasdaq

Mon, 05 Apr 2021
What Kind Of Shareholders Hold The Majority In Actinium Pharmaceuticals, Inc.'s (NYSEMKT:ATNM) Shares? - Simply Wall St

Thu, 01 Apr 2021
Do Analysts Agree Thursday on Actinium Pharmaceuticals Inc (ATNM) Stock's Target Price? - InvestorsObserver

Thu, 01 Apr 2021
The Math Shows VXF Can Go To $194 - Nasdaq

Wed, 31 Mar 2021
Actinium to Participate in the Cell & Gene Meeting on the Mediterranean - PRNewswire

Thu, 25 Mar 2021
Should You Buy Actinium Pharmaceuticals Inc (ATNM) Stock After it Is Lower By 3.57% in a Week? - InvestorsObserver

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency n/a
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Neutral Price to Earnings: Underperform
Return on Equity: Neutral Debt to Equity: Neutral
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  AMEX
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 14
Shares Float (M) 19
% Held by Insiders 1.61
% Held by Institutions 17.11
Shares Short (K) 873
Shares Short P. Month (K) 702

Stock Financials

EPS -1.830
EPS Est This Year -0.400
EPS Est Next Year -0.250
Book Value (p.s.) 3.500
Profit Margin
Operating Margin
Return on Assets (ttm) -35.8
Return on Equity (ttm) -66.3
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.) -1.615
Qtrly Earnings Growth
Operating Cash Flow (M) -22
Levered Free Cash Flow (M) -15

Stock Valuations

PE Ratio -4.14
PEG Ratio
Price to Book value 2.16
Price to Sales
Price to Cash Flow -4.76

Stock Dividends

Dividend
Forward Dividend
Dividend Yield
Dividend Pay Date 2020-08-10
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.